{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:30:49Z","timestamp":1791549049590,"version":"4.3.4"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transoral robotic surgery (TORS) or transoral laser microsurgery (TLM) offer excellent oncological outcomes for oropharyngeal squamous cell carcinoma caused by human papillomavirus (HPV) infection. TORS may offer greater margin clearance around tumors than TLM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether the differing energy sources used and surgical technique of TORS or TLM is associated with postoperative early swallowing function, feeding tube use, and specific factors related to quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prespecified cohort study was performed within the Postoperative Adjuvant Treatment for HPV-Positive Tumours (PATHOS) randomized clinical trial at 40 centers in the UK, Germany, France, the US, and Australia between November 1, 2015, and August 31, 2023. PATHOS trial participants with HPV-positive oropharyngeal carcinoma of stages T1 to T3 and N0 to N2b M0 (TNM7) who underwent TLM or TORS were eligible. Of 989 consecutively recruited patients on the PATHOS trial, 508 were eligible for this substudy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>The exposure of interest was TORS or TLM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Preplanned outcome measures included nasogastric tube insertion rates within 4 weeks after surgery, length of in-hospital stay following surgery, specific scales from the MD Anderson Dysphagia Inventory (MDADI), 35-item European Organization for Research and Treatment of Cancer Head and Neck Questionnaire (H&amp;amp;amp;N35), and 30-item Quality of Life Questionnaire (QLQ C30), water swallow test results, and videofluoroscopy scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 508 patients included in the analysis (390 [76.8%] male; median age, 58.3 [IQR, 52.8-63.6] years), 195 had TLM and 313 had TORS. Nasogastric tube insertion rates were higher after TORS than TLM (85 of 189 [45.0%] vs 10 of 126 [7.9%]; adjusted odds ratio [OR],\u20094.41 [95% CI,\u20091.01-19.32]). Mean scores favored TLM with small effect sizes in all MDADI domains and the H&amp;amp;amp;N35 swallowing item at 4 weeks after surgery; between-group difference for the MDADI composite score was \u22124.89 (95% CI, \u22128.27 to \u22121.50); for the MDADI physical functioning score, \u22126.37 (95% CI, \u221210.15 to \u22122.59); for the MDADI global score, \u221210.02 (95% CI, \u221216.50 to \u22123.54); and for H&amp;amp;amp;N35 swallowing score, 7.24 (95% CI, 2.17-12.30). No other measures showed evidence of clinically meaningful differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study, functional outcomes were moderately less impaired 4 weeks following TLM compared with TORS. Once the longer-term outcomes for these patients are known, these findings could aid the design and use of future head and neck\u2013specific surgical robots.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT02215265\">NCT02215265<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaoto.2024.3371","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T11:03:09Z","timestamp":1728558189000},"page":"1002","source":"Crossref","is-referenced-by-count":27,"title":["Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma"],"prefix":"10.1001","volume":"150","author":[{"given":"James T.","family":"O\u2019Hara","sequence":"first","affiliation":[{"name":"Population Health Sciences Institute, Newcastle University, Newcastle, United Kingdom"},{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Newcastle-upon-Tyne Hospitals NHS (National Health Service) Foundation Trust, Newcastle, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher N.","family":"Hurt","sequence":"additional","affiliation":[{"name":"Southampton Clinical Trials Unit, Southampton General Hospital, Southampton, United Kingdom"},{"name":"Centre for Trials Research, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Ingarfield","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Patterson","sequence":"additional","affiliation":[{"name":"Liverpool Head and Neck Centre, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hutcheson","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston"},{"name":"Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna E.","family":"Canham","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette S.","family":"Nixon","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie D.","family":"Heiberg","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Johson","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mererid","family":"Evans","sequence":"additional","affiliation":[{"name":"Division of Cancer and Genetics, School of Medicine, Cardiff University and Velindre University NHS Trust, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry M.","family":"Jones","sequence":"additional","affiliation":[{"name":"Liverpool Head and Neck Centre, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"ooi240075r1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"ooi240075r2","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.ejso.2020.06.045","article-title":"Transoral laser microsurgery and radiotherapy for oropharyngeal squamous cell carcinoma: equitable survival and enhanced function compared with contemporary standards of care.","volume":"46","author":"Dalton","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"ooi240075r3","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/coa.13769","article-title":"Primary transoral robotic surgery \u00b1 adjuvant therapy for oropharyngeal squamous cell carcinoma\u2014a large observational single-centre series from the United Kingdom.","volume":"46","author":"O\u2019Hara","year":"2021","journal-title":"Clin Otolaryngol"},{"key":"ooi240075r4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/issn.0065-3071","article-title":"Experience in endoscopic laser surgery of malignant tumours of the upper aero-digestive tract.","volume":"39","author":"Steiner","year":"1988","journal-title":"Adv Otorhinolaryngol"},{"issue":"12","key":"ooi240075r5","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1001\/archotol.133.12.1220","article-title":"Transoral robotic surgery: radical tonsillectomy.","volume":"133","author":"Weinstein","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ooi240075r7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s12885-015-1598-x","article-title":"PATHOS: a phase II\/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV) positive oropharyngeal cancer.","volume":"15","author":"Owadally","year":"2015","journal-title":"BMC Cancer"},{"issue":"5","key":"ooi240075r8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"ooi240075r9","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1200\/JCO.1999.17.3.1008","article-title":"Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire\u2013H&N35.","volume":"17","author":"Bjordal","year":"1999","journal-title":"J Clin Oncol"},{"issue":"7","key":"ooi240075r10","first-page":"870","article-title":"The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the MD Anderson Dysphagia Inventory.","volume":"127","author":"Chen","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"ooi240075r11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores.","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"issue":"11","key":"ooi240075r12","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.ejca.2012.02.059","article-title":"Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.","volume":"48","author":"Cocks","year":"2012","journal-title":"Eur J Cancer"},{"issue":"3","key":"ooi240075r13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s11136-021-02939-6","article-title":"Methodological approach for determining the minimal important difference and minimal important change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the swallowing scale.","volume":"31","author":"Singer","year":"2022","journal-title":"Qual Life Res"},{"issue":"5","key":"ooi240075r14","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/lary.25778","article-title":"What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients?","volume":"126","author":"Hutcheson","year":"2016","journal-title":"Laryngoscope"},{"key":"ooi240075r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2024.05.005","article-title":"A hard truth to swallow: critically evaluating the MD Anderson Dysphagia Inventory (MDADI) as an endpoint in human papillomavirus\u2013associated oropharyngeal cancer trials.","author":"McDowell","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"ooi240075r16","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.oraloncology.2009.03.012","article-title":"Swallowing performance in patients with head and neck cancer: a simple clinical test.","volume":"45","author":"Patterson","year":"2009","journal-title":"Oral Oncol"},{"key":"ooi240075r17","doi-asserted-by":"publisher","DOI":"10.1002\/hed.27885","article-title":"The timed 100 mL water swallow test for patients with head and neck cancer: what constitutes a clinically significant difference?","author":"Altamimi","year":"2024","journal-title":"Head Neck"},{"issue":"2","key":"ooi240075r18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/BF00417897","article-title":"A penetration-aspiration scale.","volume":"11","author":"Rosenbek","year":"1996","journal-title":"Dysphagia"},{"issue":"7","key":"ooi240075r19","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/cncr.34079","article-title":"Refining measurement of swallowing safety in the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) criteria: validation of DIGEST version 2.","volume":"128","author":"Hutcheson","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"ooi240075r20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/cncr.30283","article-title":"Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): scale development and validation.","volume":"123","author":"Hutcheson","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"ooi240075r21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.anl.2020.08.019","article-title":"Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.","volume":"48","author":"Sievert","year":"2021","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"ooi240075r22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1186\/s12913-021-07149-x","article-title":"Cost-utility of two minimally-invasive surgical techniques for operable oropharyngeal cancer: transoral robotic surgery versus transoral laser microsurgery.","volume":"21","author":"Parimbelli","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"ooi240075r6","unstructured":"Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS). ClinicalTrials.gov Identifier NCT02215265. Updated July 21, 2023. Accessed January 26, 2024. https:\/\/clinicaltrials.gov\/study\/NCT02215265"}],"container-title":["JAMA Otolaryngology\u2013Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2824743\/jamaotolaryngology_ohara_2024_oi_240075_1731519018.3079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:01:05Z","timestamp":1731582065000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2824743"}},"subtitle":["Secondary Analysis of the PATHOS Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2024.3371","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}